<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230820059200N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-10-03</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Shoulder arthrocentesis in two Methods with and without landmarks</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the Success rate of Shoulder Arthrocentesis &amp; Injection methods by Orthopedic surgery residents With/without landmarks</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>10</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72599</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Crossover, Purpose: Diagnostic, Randomization description: This study will be conducted as a cross-over trial in 1402 in Imam Khomeini Hospital of Tehran University of Medical Sciences and in the orthopedic department of this hospital. The study design process will be based on CONSORT guidelines. Study participants will perform shoulder arthrocentesis a total of 3 times: 1 time without landmarks, 1 time with landmarks and without traction, and 1 time with landmarks and with traction.The order of interventions in individuals will be determined in a simple random manner. At first, the necessary training regarding the anatomy of the shoulder joint and how to perform shoulder arthrocentesis with and without landmarks and, in the case of landmarks, with and without traction, will be given to the assistants by the orthopedic professor. The procedure will be performed by the "senior" resident of the group. It will be done under the supervision of the relevant teacher. Then 10 participants in the study will be randomly assigned to one of the following 6 groups and a maximum of two people will be placed in each group.Group 1: without landmark - with landmark with traction - with landmark without traction
Group 2: without landmark - with landmark without traction - with landmark with traction
Group 3: with landmark without traction - without landmark - with landmark with traction
Group 4: with landmark without traction - with landmark with traction - without landmark
Group 5: with landmark with traction - without landmark - with landmark without traction
Group 6: with landmark with traction - with landmark without traction - without landmark
For randomization, 1:1:1:1:1:1 blocks will be used and no more than two people will be placed in any of the groups. The process of randomization will be done by a person outside the research, and the researcher and assistants participating in the research will not be aware of the process. This is for Allocation Concealment, so that there is no intervention in terms of allocation of interventions by the research team, Blinding description: The researchers and the statistical analyst will not be aware of the intervention and the interventions will be defined as A, B, and C by a person outside the research for the researchers and the team of researchers from the assigned order and also the definition of the codes until after the implementation. Research will not be informed. In this way, the study will be done in a double-blind manner.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Evaluation of the success rate of shoulder arthrocentesis &amp; injection methods by orthopedic surgery residents with/without landmarks.</hc_freetext>
      <i_freetext>Intervention 1: First intervention :Insertion of the angiocath needle only once without drawing an anatomical landmark and in the condition that the hand is not in traction. Intervention 2: Second Intervention: assistant on the same patient as the first intervention; will perform the second intervention: the second intervention: entering only one time of the angiocath needle based on drawing the anatomical landmarks and while the patient's hand is not in traction. Intervention 3: Third Intervention: assistant on the same patient as the first intervention; He will perform the third intervention: The third intervention: the insertion of only one time of the angiocath needle based on the drawing of anatomical landmarks and while the patient's hand is in traction.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The release of more information will happen after the end of the study based on a specific plan that is not yet clear</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyyed Hosein Jahanbakhsh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 35, Barati avenue, Ayat avenue, Nobovat square, Narmak</address>
        <city>تهران</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1648819813</zip>
        <telephone>+98 21 7790 0924</telephone>
        <email>dr.s.h.jahanbakhsh@gmail.com</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Reza Guity</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Imam khomeini hospital,keshavarz ave,Tehran town</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۴۱۹۷۳۳۱۴۱</zip>
        <telephone>00982161190</telephone>
        <email>Imamhospital@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>The patient's age is between 18 and 70 years old 

Diagnosis requiring arthroscopic surgery of the shoulder, such as rotator cuff tears, labrum repair, etc.                                           
Consent to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Existence of anatomic abnormality in pre-surgery imaging
Previous arthroscopy in which the previous incision has remained</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Early detection</i_code>
      <i_code>Early detection</i_code>
      <i_code>Early detection</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>First intervention :Insertion of the angiocath needle only once without drawing an anatomical landmark and in the condition that the hand is not in traction</i_keyword>
      <i_keyword>Second Intervention: assistant on the same patient as the first intervention; will perform the second intervention: the second intervention: entering only one time of the angiocath needle based on drawing the anatomical landmarks and while the patient's hand is not in traction</i_keyword>
      <i_keyword>Third Intervention: assistant on the same patient as the first intervention; He will perform the third intervention: The third intervention: the insertion of only one time of the angiocath needle based on the drawing of anatomical landmarks and while the patient's hand is in traction.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Success rate of orthopedic assistants in performing shoulder arthrocentesis. Timepoint: The time period of the variable measurement is during the same day during the arthroscopic surgery. Method of measurement: After the complete arthrocentesis, the entry of the needle into the joint space will be evaluated by the arthroscope, and the assistant's performance will be graded from 0 to 2 by the professor:0 (not entering the shoulder joint)1 (entering the shoulder joint through the rotator cuff or biceps)2 (Entry through rotator interval)-In other words, the assistant's success in entering the Angiocath  into the shoulder joint space will be checked with an arthroscope and scoring will be done as described above.</prim_outcome>
      <prim_outcome>Duration of arthrocentesis. Timepoint: The time period of the variable measurement is during the same day during the arthroscopic surgery. Method of measurement: At the same time as the landmark is drawn, the time is measured with a stopwatch and ends after the needle enters the skin, and the procedure time is measured in seconds.</prim_outcome>
      <prim_outcome>The ease of performing the procedure according to the assistant based on the Likert scale. Timepoint: The time period of the variable measurement is during the same day during the arthroscopic surgery. Method of measurement: The ease of performing the procedure is given a score by the resident who performed the procedure based on a Likert scale from 1 (least ease) to 10 (maximum ease).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-06-20</approval_date>
        <contact_name>Research Ethics Committee of Imam Khomeini Hospital Complex - Tehran University of Medical Sciences</contact_name>
        <contact_address>No 35, Barati avenue, Ayat avenue, Nobovat square, Narmak Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
